CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...
News Medical on MSN4h
TLE6 Protein Linked to Male Mice InfertilityInfertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect early embryonic ...
MarketBeat on MSN3h
Vertex's Pain Drug: Big Pharma's Next Major Success?Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...
AZoLifeSciences on MSN13h
Base Editing Technique Extends Lifespan in Prion Disease Mouse ModelResearchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...
"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...
Researchers explored the role of the TLE6 protein in male fertility using a novel mouse model. TLE6 deficiency caused ...
CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback